Guardant Health (GH) announced a strategic collaboration with Pfizer, Inc. (PFE), to support the development and commercialization of Pfizer's oncology portfolio using the Guardant Infinity smart liquid biopsy platform. The collaboration will also provide Pfizer with access to Guardant's liquid biopsy tests in China for their global clinical trials that include China cohorts.
Guardant and Pfizer aim to utilize Guardant's portfolio of liquid biopsy tests in Pfizer's global clinical studies, and evaluate the clinical utility of: circulating tumor DNA level as a surrogate endpoint to monitor therapy response; and related blood-based epigenomic analyses.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.